Theriva Biologics (TOVX) Non-Current Deferred Tax Liability (2022 - 2023)
Theriva Biologics (TOVX) posted quarterly Non-Current Deferred Tax Liability of $413000.0 for Q3 2023, down 79.18% year-over-year from $2.0 million in Q3 2022, and down 56.62% quarter-over-quarter from $952000.0 in Q2 2023.
Theriva Biologics (TOVX) Non-Current Deferred Tax Liability (2022 - 2023) Analysis & Trends
Theriva Biologics (TOVX) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $413000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Non-Current Deferred Tax Liability fell 79.18% year-over-year to $413000.0; the TTM figure through Sep 2023 stood at $413000.0 (down 79.18% YoY), while the FY2022 annual figure was $1.6 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability retreated to $413000.0 in Q3 2023 per TOVX's latest filing, from $952000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $3.7 million in Q1 2022 and bottomed at $413000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 413,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Jun 30, 2023 | 952,000.00 |
| Jun 30, 2023 | 952,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 2.29 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Mar 31, 2022 | 3.73 Mn |